I agree that this site is using cookies. You can find further informations here.
X
Steven Ernest II, C.
165  results:
Search for persons X
?
1

A population pharmacokinetic model using allometric scaling..:

Decker, Rodney L. ; Steven Ernest II, C. ; Radtke, David B....
CPT: Pharmacometrics & Systems Pharmacology.  13 (2024)  6 - p. 970-981 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Optimal clinical trial design based on a dichotomous Markov..:

Steven Ernest II, C. ; Nyberg, Joakim ; Karlsson, Mats O..
Journal of Pharmacokinetics and Pharmacodynamics.  41 (2014)  6 - p. 639-654 , 2014
Link: https://doi.org/10.1007/..
 
?
3

Donanemab exposure and efficacy relationship using modeling..:

Gueorguieva, Ivelina ; Willis, Brian A. ; Chua, Laiyi...
Alzheimer's & Dementia: Translational Research & Clinical Interventions.  9 (2023)  2 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
4

PK/PD modeling links accelerated resolution of COVID‐19‐rel..:

Ernest II, C. Steven ; Chien, Jenny Y. ; Patel, Dipak R..
CPT: Pharmacometrics & Systems Pharmacology.  11 (2022)  6 - p. 721-730 , 2022
Link: https://doi.org/10.1002/..
 
?
5

Simultaneous optimal experimental design for in vitro bindi..:

Ernest II, C. Steven ; Karlsson, Mats O. ; Hooker, Andrew C.
Journal of Pharmacokinetics and Pharmacodynamics.  40 (2013)  5 - p. 573-585 , 2013
Link: https://doi.org/10.1007/..
 
?
6

Relationship Between Exposure to Prasugrel Active Metabolit..:

Riesmeyer, Jeffrey S. ; Salazar, Daniel E. ; Weerakkody, Govinda J....
The Journal of Clinical Pharmacology.  52 (2012)  6 - p. 789-797 , 2012
Link: https://doi.org/10.1177/..
 
?
7

Integrated Analysis of Pharmacokinetic Data Across Multiple..:

Small, David S. ; Li, Ying G. ; Ernest II, C. Steven...
The Journal of Clinical Pharmacology.  51 (2011)  3 - p. 321-332 , 2011
Link: https://doi.org/10.1177/..
 
?
8

Methodological Comparison of In Vitro Binding Parameter Est..:

Ernest II, C. Steven ; Hooker, Andrew C. ; Karlsson, Mats O.
Pharmaceutical Research.  27 (2010)  5 - p. 866-877 , 2010
Link: https://doi.org/10.1007/..
 
?
9

Population Pharmacokinetic Analyses to Evaluate the Influen..:

Wrishko, Rebecca E. ; Ernest II, C. Steven ; Small, David S....
The Journal of Clinical Pharmacology.  49 (2009)  8 - p. 984-998 , 2009
Link: https://doi.org/10.1177/..
 
?
10

Prediction of Prasugrel Active Metabolite Concentrations Fr..:

Ernest II, C. Steven ; Heathman, Michael A. ; Wrishko, Rebecca E.
The Journal of Clinical Pharmacology.  49 (2009)  8 - p. 973-983 , 2009
Link: https://doi.org/10.1177/..
 
?
11

Effect of Age on the Pharmacokinetics and Pharmacodynamics ..:

Small, David S. ; Wrishko, Rebecca E. ; Ernest II, C. Steven...
Drugs & Aging.  26 (2009)  9 - p. 781-790 , 2009
Link: https://doi.org/10.2165/..
 
?
12

Effect of Atorvastatin on the Pharmacokinetics and Pharmaco..:

Farid, Nagy A. ; Small, David S. ; Payne, Christopher D....
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  28 (2008)  12 - p. 1483-1493 , 2008
Link: https://doi.org/10.1592/..
 
?
13

Prasugrel, a New Thienopyridine Antiplatelet Drug, Weakly I..:

Farid, Nag A. ; Payne, Christophe D. ; Ernest II, C. Steven...
The Journal of Clinical Pharmacology.  48 (2008)  1 - p. 53-59 , 2008
Link: https://doi.org/10.1177/..
 
?
14

Population pharmacokinetics and pharmacodynamics of prasugr..:

Ernest II, C. Steven ; Small, David S. ; Rohatagi, Shashank...
Journal of Pharmacokinetics and Pharmacodynamics.  35 (2008)  6 - p. 593-618 , 2008
Link: https://doi.org/10.1007/..
 
?
15

Donanemab exposure and efficacy relationship using modeling..:

Ivelina Gueorguieva ; Brian A. Willis ; Laiyi Chua...
https://doi.org/10.1002/trc2.12404.  , 2023
Link: https://doi.org/10.1002/..
 
1-15